PETER BRENT, SAMPSON,MIKLOS, FEHER,HEINZ W., PAULS
申请号：
TR201902875
公开号：
TR201902875T4
申请日:
2014.10.17
申请国别(地区):
TR
年份:
2019
代理人:
摘要：
Disclose the fumarate and maleate and their corresponding pharmaceutical compositions of the compound (I) indicated by following structural formula. The specific monocrystalline type of 1:1 compound (I) fumarate and 1:1 compound (I) maleate is characterized by a variety of properties and physical measurement. Also disclose the method for preparing the specific crystal formation of 1:1 compound (I) fumarate and 1:1 compound (I) maleate. The method of subject the present invention also provides treatment with cancer. Mevcut buluş, PLK-4 inhibitörünün tuz ve kristal formları ile ilgilidir.
